Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ)

CNY 15.39

(0.33%)

Market Cap (In CNY)

14.87 Billion

Revenue (In CNY)

1.46 Billion

Net Income (In CNY)

43.93 Million

Avg. Volume

24.16 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.12-22.15
PE
240.83
EPS
0.06
Beta Value
0.278
ISIN
CNE000000735
CUSIP
-
CIK
-
Shares
966495000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Hongjun Zhan
Employee Count
-
Website
https://www.thjm.cn
Ipo Date
1997-04-30
Details
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers its products in the form of capsules, tablets, injections, liquids, etc. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. was founded in 1990 and is based in Tonghua, China.